Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...

On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...

A US Supreme Court fight over how branded drugs’ makers must plead induced infringement in “skinny-label” patent suits could ...

Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.

FDA’s recent draft guidance, Regulatory Considerations for Prescription Drug Use Related Software, proposes a regulatory framework for software disseminated by a drug sponsor that supplements or ...

Pharmaceutical companies are in the hot seat for allegedly pushing drugs for uses not approved by the government, a growing practice that has triggered a congressional investigation, litigation and ...

SPENCER, Mass.--(BUSINESS WIRE)--FLEXcon Company, Inc., an innovator in adhesive coating and laminating, today announced the relaunch of its FLEXcon® PHARMcal® line of track and trace solutions ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Project Renewal updates older oncology drug labels to ensure clinical relevance and scientific accuracy, involving external experts and early-career scientists. Fludarabine phosphate's updated label ...

Please provide your email address to receive an email when new articles are posted on . Mebeverine was not superior to placebo, with similar treatment success and symptom relief reported between ...

Physicians are increasingly prescribing medications off-label to children, with one-fifth of all pediatric physician visits resulting in off-label prescriptions, according to a study published in ...